Cassandra M. Klosterman AubertAssociate Foley & Lardner LLPWebsitewww.foley.comOrganization ProfileFull ProfileBlogwww.foley.com/en/general/foley-blogs-and-podcastsConnectEmailTwitterLinkedIn202-295-4150 Professional Biography Cassandra Klosterman is an associate working with the Business Litigation & Dispute Resolution group in the firm’s Washington, D.C. office. More Legal and Business Bylines From Cassandra M. Klosterman Aubert SEC Enforcement Action Against Church & Dwight Director: Lessons for Outside Directors - (Posted On Tuesday, December 31, 2024) DOJ to Ramp up Antitrust Enforcement in Agriculture Sector - (Posted On Monday, July 08, 2024) Driving Tomorrow’s Advances in the Health Care and Life Sciences Ecosystems [Video] - (Posted On Monday, May 20, 2024) Current Legal Analysis FDA Warning Letter Takes Issue with Designation of Substance as Dietary Ingredient by: Food and Drug Law at Keller and Heckman Understanding Small Business Size and Status Protests and Appeals: A Guide for Government Contractors by: Aron C. Beezley , Gabrielle A. Sprio Nebraska to Restrict SNAP Soda and Energy Drink Purchases by: Food and Drug Law at Keller and Heckman CPSC Withdraws Lithium-Ion Battery Rulemaking by: Sheila A. Millar , Antonia Stamenova-Dancheva Should Nevada Corporations Say Goodbye To Ratification Of Auditor Appointments? by: Keith Paul Bishop FTC Delays Enforcement of Click-to-Cancel Rule by: Sheila A. Millar , Antonia Stamenova-Dancheva Court of Appeals Ruling in Nellenback Provides CVA Clarity by: Gary J. Intoccia PTAB Rejects AI-Driven Medical Patent – Not for Novelty, But Eligibility by: James W. Soong Department of Energy Announces Initiative to Review the Agency’s Federal Awards by: Robert J. Wagman, Jr. , Nicole Boeckmann Changes in Migratory Bird Treaty Act Protections – Impacts on Project Development by: Ana Maria Gutierrez , Jessica Portmess Considerations for Life Sciences Employers When Planning Reductions in Force by: Mark H. Burak , David J.B. Froiland Clawback Enforcement Under SEC Rule 10D-1 by: Matthew R. Zischke The Trump Administration Announces Price Targets as It Takes a Second Swing at “Most Favored Nation” Drug Pricing Model by: Claire Davies , Suzanne E. Bassett FDA Advances Post-Market Chemical Review Program by: Lynn L. Bergeson , Carla N. Hutton GeTtin’ SALTy Episode 53 | GeTtin' SALTy & Beyond: Exploring Extended Producer Responsibility Laws [Podcast] by: Nikki E. Dobay , Madeline Orlando Upcoming Events May 22 2025 Kidd Aitken & Chambers USA Q&A May 22 2025 Yours, Mine, or Ours? The Complex and Often Competing Duties Owed by Agents and Brokers to Their Insurers and Insureds May 22 2025 A Practical Understanding of Intellectual Property May 27 2025 Making a Mountain Out of a Mole Hill: Damage Escalation Strategies in Property Claims Print
